Radioactive drug trial offers hope for aggressive brain cancer

NCT ID NCT05739942

Ongoing Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new radioactive drug called [177Lu]Lu-NeoB for people with glioblastoma, a fast-growing brain cancer. For newly diagnosed patients, the drug is given alongside standard radiation and chemotherapy. For those whose cancer has returned, it's given alone. The main goals are to find a safe dose and see how well the body tolerates the treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Dana Farber Cancer Institute

Boston, Massachusetts, 02215, United States
Mayo Clinic Jacksonville

Jacksonville, Florida, 32224, United States
Memorial Sloan Kettering Cancer Ctr

New York, New York, 10065, United States
Novartis Investigative Site

Dijon, Cote D Or, 21034, France
Novartis Investigative Site

Marseille, 13885, France
Novartis Investigative Site

Cologne, North Rhine-Westphalia, 50937, Germany
Novartis Investigative Site

Essen, 45147, Germany
Novartis Investigative Site

München, 80377, Germany
Novartis Investigative Site

Rostock, 18057, Germany
Novartis Investigative Site

Jerusalem, 9112001, Israel
Novartis Investigative Site

Reggio Emilia, RE, 42123, Italy
Novartis Investigative Site

Porto, 4200-072, Portugal
Novartis Investigative Site

Granada, Andalusia, 18014, Spain
Novartis Investigative Site

Badalona, Catalonia, 08916, Spain
Novartis Investigative Site

Barcelona, Catalonia, 08003, Spain
Novartis Investigative Site

Barcelona, 08907, Spain
Novartis Investigative Site

Madrid, 28009, Spain
Novartis Investigative Site

Madrid, 28040, Spain
Novartis Investigative Site

Liverpool, CH63 4JY, United Kingdom
Uni of Utah Huntsman Cancer Inst

Salt Lake City, Utah, 84103, United States
Univ Hosp Cleveland Medical Center

Cleveland, Ohio, 44106-5028, United States
University of California LA

Los Angeles, California, 90095, United States
University of Colorado Denver

Aurora, Colorado, 80045, United States

Conditions

Explore the condition pages connected to this study.

NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA